Mc Kechnie Duncan Insider Trades

Insider Trading History

Track insider trading activity for Mc Kechnie Duncan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $5.85M 12,489 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.31M 2,633 shares
$498.42
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $7.08M 15,122 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.16M 2,437 shares
$475.30
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $8.22M 17,559 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.18M 2,410 shares
$489.00
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $9.35M 19,969 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.22M 2,500 shares
$486.35
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $10.5M 22,469 shares
Last Trade
Feb 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$424k 873 shares
$485.11
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $10.9M 23,342 shares
Last Trade
Feb 17, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$555k 1,148 shares
$483.75
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $11.5M 24,490 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 4,962 shares
$477.40
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $9.14M 19,528 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.11M 2,283 shares
$487.76
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $10.2M 21,811 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$528k 1,127 shares
$468.41
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $9.77M 20,858 shares
Last Trade
Jan 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.21M 4,720 shares
$467.35
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
Evp, Chief Commercial Officer
Holding Value $10.7M 22,938 shares
Last Trade
Jan 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$972k 2,080 shares
$467.35
$468.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up